MRI scan with a special agent to assess brain tumors
Treatments studied
Part of Cancer clinical trials.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old, and you’re expected to live more than 12 weeks
- Your general functioning is decent (Karnofsky score 60 or higher)
- You must be able to get the scan after recent kidney blood tests are checked (creatinine under 1.5 mg/dL within 60 days of the scan)
- You should not have major heart problems (including heart failure beyond mild, or a heart attack/unstable chest pain in the last 12 months)
- You must not have uncontrolled serious illnesses that could make the scan unsafe or hide side effects
- You must be able to follow study steps and visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study (Phase 1) tests a new kind of MRI that uses a special labeled sugar (pyruvate) to help learn how infiltrating gliomas behave in the brain. If you have a suspected or known infiltrating glioma and are having brain surgery or biopsy, this may help your doctors learn more about tumor metabolism and guide future care.
This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This study uses an advanced MRI scan to help doctors tell the difference between radiation scar (radiation necrosis) and returning glioma (recurrent glioma) after prior treatment. It may help guide the next steps for care if you have a new or changing brain lesion.
This study uses special MRI scans to better “characterize” (study) gliomas, a type of brain tumor, using information from your brain tissue. You may be eligible if you’re an adult with a suspected or confirmed glioma and you already need a biopsy or surgery.
This Phase 1 study uses special MRI scans (including a form of MR spectroscopy) to better understand lower-grade gliomas. It is designed to test how well the imaging can “characterize” the tumor and to improve understanding for treatment planning.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.